PharmChem, Inc. (PCHM)
USD 2.98
(0.0%)
USD 2.98
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.49 Million USD | 54.49% |
| 2022 | -3.28 Million USD | -48.09% |
| 2021 | -2.21 Million USD | 71.24% |
| 2020 | -7.7 Million USD | -25.94% |
| 2019 | -6.12 Million USD | -22.16% |
| 2018 | -5.01 Million USD | -29.89% |
| 2017 | -3.85 Million USD | -31.75% |
| 2016 | -2.92 Million USD | 0.0% |
| 2002 | 2.32 Million USD | -78.67% |
| 2001 | 10.89 Million USD | 414.74% |
| 2000 | 2.11 Million USD | -6.54% |
| 1999 | 2.26 Million USD | -16.09% |
| 1998 | 2.69 Million USD | -45.03% |
| 1997 | 4.9 Million USD | 48.73% |
| 1996 | 3.3 Million USD | -17.5% |
| 1995 | 4 Million USD | -16.67% |
| 1994 | 4.8 Million USD | 4.35% |
| 1993 | 4.6 Million USD | 666.67% |
| 1992 | 600 Thousand USD | 105.31% |
| 1991 | -11.3 Million USD | -694.74% |
| 1990 | 1.9 Million USD | 58.33% |
| 1989 | 1.2 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1.73 Million USD | -15.79% |
| 2024 Q2 | -2.23 Million USD | -29.45% |
| 2023 FY | -1.49 Million USD | 54.49% |
| 2023 Q1 | -2.01 Million USD | 38.62% |
| 2023 Q2 | -2.07 Million USD | -3.17% |
| 2023 Q3 | -2.09 Million USD | -0.82% |
| 2023 Q4 | -1.49 Million USD | 28.71% |
| 2022 FY | -3.28 Million USD | -48.09% |
| 2022 Q2 | -2.25 Million USD | 0.3% |
| 2022 Q4 | -3.28 Million USD | -16.7% |
| 2022 Q1 | -2.26 Million USD | -1.96% |
| 2022 Q3 | -2.81 Million USD | -24.83% |
| 2021 Q2 | -7.44 Million USD | 0.0% |
| 2021 Q4 | -2.21 Million USD | 54.97% |
| 2021 FY | -2.21 Million USD | 71.24% |
| 2021 Q3 | -4.92 Million USD | 33.9% |
| 2020 FY | -7.7 Million USD | -25.94% |
| 2019 FY | -6.12 Million USD | -22.16% |
| 2018 FY | -5.01 Million USD | -29.89% |
| 2017 FY | -3.85 Million USD | -31.75% |
| 2016 FY | -2.92 Million USD | 0.0% |
| 2003 Q1 | 3.13 Million USD | 34.74% |
| 2003 Q2 | 3.07 Million USD | -1.63% |
| 2003 Q3 | 3.21 Million USD | 4.55% |
| 2002 Q4 | 2.32 Million USD | -22.75% |
| 2002 Q1 | 1.95 Million USD | -82.05% |
| 2002 FY | 2.32 Million USD | -78.67% |
| 2002 Q2 | 2.58 Million USD | 32.28% |
| 2002 Q3 | 3 Million USD | 16.28% |
| 2001 FY | 10.89 Million USD | 414.74% |
| 2001 Q2 | 7.7 Million USD | 68.35% |
| 2001 Q3 | 9.67 Million USD | 25.56% |
| 2001 Q4 | 10.89 Million USD | 12.56% |
| 2001 Q1 | 4.57 Million USD | 116.35% |
| 2000 Q2 | 3.66 Million USD | 1.27% |
| 2000 Q4 | 2.11 Million USD | -43.01% |
| 2000 FY | 2.11 Million USD | -6.54% |
| 2000 Q1 | 3.62 Million USD | 59.94% |
| 2000 Q3 | 3.71 Million USD | 1.25% |
| 1999 Q3 | 3.2 Million USD | 0.0% |
| 1999 FY | 2.26 Million USD | -16.09% |
| 1999 Q4 | 2.26 Million USD | -29.25% |
| 1999 Q2 | 3.2 Million USD | 14.29% |
| 1999 Q1 | 2.8 Million USD | 3.78% |
| 1998 Q4 | 2.69 Million USD | -15.69% |
| 1998 FY | 2.69 Million USD | -45.03% |
| 1998 Q3 | 3.2 Million USD | -33.33% |
| 1998 Q2 | 4.8 Million USD | 11.63% |
| 1998 Q1 | 4.3 Million USD | -12.39% |
| 1997 Q3 | 4.9 Million USD | 11.36% |
| 1997 Q1 | 3.3 Million USD | 0.0% |
| 1997 FY | 4.9 Million USD | 48.73% |
| 1997 Q2 | 4.4 Million USD | 33.33% |
| 1997 Q4 | 4.9 Million USD | 0.16% |
| 1996 FY | 3.3 Million USD | -17.5% |
| 1996 Q2 | 6 Million USD | 27.66% |
| 1996 Q4 | 3.3 Million USD | -23.26% |
| 1996 Q3 | 4.3 Million USD | -28.33% |
| 1996 Q1 | 4.7 Million USD | 17.5% |
| 1995 FY | 4 Million USD | -16.67% |
| 1995 Q4 | 4 Million USD | 8.11% |
| 1995 Q1 | 4.6 Million USD | -4.17% |
| 1995 Q3 | 3.7 Million USD | 0.0% |
| 1994 Q4 | 4.8 Million USD | 14.29% |
| 1994 Q3 | 4.2 Million USD | 0.0% |
| 1994 Q1 | 5.1 Million USD | 10.87% |
| 1994 FY | 4.8 Million USD | 4.35% |
| 1993 FY | 4.6 Million USD | 666.67% |
| 1993 Q2 | 2.7 Million USD | 0.0% |
| 1993 Q3 | 3.6 Million USD | 33.33% |
| 1993 Q4 | 4.6 Million USD | 27.78% |
| 1992 Q4 | 600 Thousand USD | 0.0% |
| 1992 FY | 600 Thousand USD | 105.31% |
| 1991 FY | -11.3 Million USD | -694.74% |
| 1991 Q4 | -11.3 Million USD | 0.0% |
| 1990 Q4 | 1.9 Million USD | 0.0% |
| 1990 FY | 1.9 Million USD | 58.33% |
| 1989 FY | 1.2 Million USD | 0.0% |
| 1989 Q4 | 1.2 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | 167.743% |
| Arrayit Corporation | 1.05 Million USD | 241.573% |
| Atlantic International Corp. | 236.49 Thousand USD | 731.898% |
| Biocept, Inc. | -788 Thousand USD | -89.646% |
| Bioqual, Inc. | -12 Million USD | 87.554% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | 6672.026% |
| DermTech, Inc. | 17.65 Million USD | 108.465% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 99.739% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 79.742% |
| iMD Companies, Inc. | 1.11 Million USD | 233.918% |
| IDenta Corp. | 524.85 Thousand USD | 384.73% |
| Interpace Biosciences, Inc. | 7.69 Million USD | 119.423% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | -5444.72% |
| InVitro International | -313.14 Thousand USD | -377.232% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | 195.434% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | -209495.091% |
| Medical Imaging Corp. | 3.79 Million USD | 139.421% |
| NovelStem International Corp. | 3.52 Million USD | 142.436% |
| Optigenex Inc. | 8.93 Million USD | 116.727% |
| Proteome Sciences plc | 14.57 Million USD | 110.254% |
| Response Genetics, Inc | -13.08 Million USD | 88.58% |
| Rennova Health, Inc. | 14.82 Million USD | 110.077% |
| RushNet, Inc. | 4.8 Million USD | 131.128% |
| ScreenPro Security Inc. | 135.58 Thousand USD | 1202.164% |
| Stella Diagnostics Inc. | 6.19 Million USD | 124.13% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | 183.749% |
| Todos Medical Ltd. | 38.31 Million USD | 103.9% |